Literature DB >> 12426617

Schistosomiasis mansoni in Bananal (State of São Paulo, Brazil): I. Efficiency of diagnostic and treatment procedures.

Horacio Manuel Santana Teles1, Maria Esther de Carvalho, Cláudio Santos Ferreira, Fabiana Zacharias, Valquíria Rosa de Lima, Maria Lucia Condino Fadel.   

Abstract

Bananal is an important focus of Schistosoma mansoni in the State of São Paulo. Accordingly, programmed active search for human cases, annual coproscopic surveys and treatment of infected cases were started in 1998, aiming at producing a sharp prevalence rate drop by the year 2000. S. mansoni eggs were searched for in two Kato-Katz slides per patient. Cases were followed up according to the routine of the local Family Health Program. In 1998, 130 samples out of 3,860 showed S. mansoni eggs; in 1999, 105 out of 3,550, and in 2000, 64 out of 3,528. Prevalence rates were 3.4%, 2.9%, and 1.8%, and average egg-counts 59, 64, and 79 eggs per gram of feces respectively. Prevalence rates decreased steadily after treatment, but persistently positive cases showed no significant decrease in parasite burdens. Egg count variation depended on sex and age bracket. Persistent residual cases admittedly preclude the eradication of this infection by only searching for and treating carriers. In addition, resistance to therapy and low sensitivity of fecal examinations, can not be ignored. Moderate to heavy worm burdens, frequently associated with hepatomegaly elsewhere, produced no serious cases in Bananal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426617     DOI: 10.1590/s0074-02762002000900035

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  5 in total

1.  Detection of Schistosoma mansoni antibodies in a low-endemicity area using indirect immunofluorescence and circumoval precipitin test.

Authors:  Maria Cristina Carvalho do Espírito-Santo; Pedro Luiz Pinto; Cybele Gargioni; Monica Viviana Alvarado-Mora; Vera Lúcia Pagliusi Castilho; João Ranato Rebello Pinho; Expedito José de Albuquerque Luna; Ronaldo Cesar Borges Gryschek
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

2.  Evaluation of the sensitivity of IgG and IgM ELISA in detecting Schistosoma mansoni infections in a low endemicity setting.

Authors:  M C C Espirito-Santo; M C A Sanchez; A R Sanchez; M V Alvarado-Mora; V L P Castilho; E M N Gonçalves; E J A Luna; R C B Gryschek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-17       Impact factor: 3.267

Review 3.  The Advances in Molecular and New Point-of-Care (POC) Diagnosis of Schistosomiasis Pre- and Post-praziquantel Use: In the Pursuit of More Reliable Approaches for Low Endemic and Non-endemic Areas.

Authors:  Marta G Cavalcanti; Aline Fernandes Araujo Cunha; José Mauro Peralta
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

4.  Comparative Study of the Accuracy of Different Techniques for the Laboratory Diagnosis of Schistosomiasis Mansoni in Areas of Low Endemicity in Barra Mansa City, Rio de Janeiro State, Brazil.

Authors:  Maria Cristina Carvalho Espírito-Santo; Mónica Viviana Alvarado-Mora; Pedro Luiz Silva Pinto; Maria Carmen Arroyo Sanchez; Emmanuel Dias-Neto; Vera Lúcia Pagliusi Castilho; Elenice Messias do Nascimento Gonçalves; Pedro Paulo Chieffi; Expedito José de Albuquerque Luna; João Renato Rebello Pinho; Flair José Carrilho; Ronaldo Cesar Borges Gryschek
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

5.  Reduced susceptibility of a Biomphalaria tenagophila population to Schistosoma mansoni after introducing the resistant Taim/RS strain of B. tenagophila into Herivelton Martins stream.

Authors:  Daisymara Priscila de Almeida Marques; Florence Mara Rosa; Engels Maciel; Deborah Negrão-Corrêa; Horácio Manuel Santana Teles; Roberta Lima Caldeira; Liana Konovaloff Jannotti-Passos; Paulo Marcos Zech Coelho
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.